News in Numbers
2028
The EMA and the Heads of Medicines Agencies have published their artificial intelligence workplan, which seeks to maximise the technology’s benefits while handling its risks until 2028.
2 billion
The COVAX Covid-19 vaccine delivery program has delivered nearly 2 billion doses of vaccines to 146 economies as of 31 December, 2023.
3
The EU will be the third market with the world’s first CRISPR-based gene therapy Casvegy as the bloc’s health agency recommended the product’s approval.
$14bn
Bristol Myers Squibb has paid $14 billion to acquire the biopharma company Karuna Therapeutics as part of its plans to bolster its neuroscience portfolio.
$92.5m
Alkermes sold its manufacturing facility in Ireland to Novo Nordisk for $92.5m as part of the Danish pharma giant’s plans to meet the growing demand for its drugs.
